MERETEK UBT KIT (W/ PRANACTIN)
LOE ApproachingNDAORALFOR SOLUTION
Approved
Sep 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MERETEK UBT KIT (W/ PRANACTIN) is an oral diagnostic solution kit used for urea breath testing, approved by Otsuka in 1996. The product facilitates non-invasive detection of Helicobacter pylori infection through breath analysis. It represents a specialized diagnostic modality rather than a therapeutic agent.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating consolidation or transition planning for commercial teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings indicate minimal hiring activity, reflecting LOE-stage product lifecycle. Career opportunities center on defensive positioning, market retention, and transition planning rather than growth or expansion.
Diagnostic Product ManagerField Sales Representative
Worked on MERETEK UBT KIT (W/ PRANACTIN) at Otsuka? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.